The Hanover Insurance Group, Inc. filings document the regulatory record of a property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Its 8-K reports include results of operations and financial condition, earnings releases and unaudited financial supplements covering underwriting metrics, catastrophe losses, premiums, investment income, book value and related insurance performance measures.
The company’s proxy materials cover annual meeting procedures, shareholder voting matters, board governance and executive compensation disclosures. Other filings record capital-structure activity, including senior unsecured notes, note redemptions, registration-statement references and Form 25 records for the removal of a senior debenture class from exchange listing and registration.
Hanover Insurance Group executive Jeffrey M. Farber reported multiple equity awards tied to the company’s long-term incentive plan. On February 24, 2026, he acquired 14,436 stock options at an exercise price of $0.0000 per share.
He also acquired 5,043, 3,250 and 3,025 shares of common stock through performance-based and time-based restricted stock units granted under the 2022 Long-Term Incentive Plan. Certain performance-based awards had their performance conditions certified and are scheduled to vest on February 27, 2026.
Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported equity awards under the company’s long-term incentive plans. On February 24, 2026, he acquired 5,328 stock options with an exercise price of $0.0000 per share and 1,730 shares of common stock at no cost.
He also received additional common stock awards of 1,115 shares and 1,117 shares, each reported as grants or other acquisitions, bringing his direct common stock holdings to 13,719.585 shares. Footnotes indicate that related performance-based and restricted stock unit awards vest over multi‑year periods, with some vesting on February 27, 2026, and options vesting in thirds on each of the first three anniversaries of grant.
Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity awards tied to the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 9,968 stock options at an exercise price of $0.00 per share and several stock-based awards totaling 6,828 common shares at no cost.
The stock awards reflect performance-based restricted stock units whose performance conditions were certified at 150% and 100% of target, plus a time-based restricted stock unit grant. The performance-based awards are scheduled to vest on February 27, 2026, while other units and options vest over a three-year period.
HANOVER INSURANCE GROUP, INC. Executive Vice President David John Lovely reported equity awards rather than open‑market trades. On February 24, 2026, he acquired a stock option for 3,781 shares at a grant price of $0.00 per share and several stock grants also at no cost.
The filing shows three separate common stock awards of 1,082, 698, and 793 shares, all recorded as grants or awards. Footnotes explain these awards relate to performance‑based and time‑based restricted stock units under the company’s 2022 Long‑Term Incentive Plan, with vesting tied to February 27, 2026 or later anniversaries.
Hanover Insurance Group Executive Vice President Denise Lowsley reported equity awards and vesting-related share grants. On February 24, 2026, she was granted a stock option for 3,094 shares of common stock, which vests in three equal annual installments from the grant date.
She also acquired 1,154 restricted stock units that vest on the third anniversary of grant. In addition, performance-based restricted stock unit awards granted in 2023 had their performance conditions certified, resulting in 744 shares tied to a 150% performance outcome and 649 shares tied to a 100% performance outcome, both still subject to time-based vesting through February 27, 2026.
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. President and CEO John C. Roche reported equity awards tied to the company’s long-term incentive plan. He received an option to buy 45,025 shares of common stock, plus stock-based awards totaling 31,229 shares at no cash cost to him.
Footnotes explain that these grants reflect performance-based restricted stock units from a 2023 award, with performance certified at 150% and 100% of target and vesting on February 27, 2026, as well as new restricted stock units and options that generally vest over three years.
Hanover Insurance Group Executive Vice President Salvatore Bryan J reported equity awards and vesting-related acquisitions of company stock and options. On February 24, 2026, he received a grant of 8,937 common stock options at a price of $0 per share.
He also acquired common shares through performance-based restricted stock units and restricted stock units. These include awards of 2,595, 1,672, and 1,873 common shares, all at $0 per share. Two PBRSU awards granted in 2023 had their performance conditions certified at 150% and 100% of target and remain subject to time-based vesting until February 27, 2026. A separate RSU grant vests on the third anniversary of grant, and the options vest in three equal annual installments.
Hanover Insurance Group Executive Vice President T. Willard Lee reported equity awards under the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 3,781 stock options with an exercise right described as a common stock option. These options vest in three equal annual installments on each of the first three anniversaries of the grant date.
On the same date, he also acquired a total of 2,691 shares or units of common stock at no cost in multiple grants. Footnotes explain that earlier performance-based restricted stock units granted on February 27, 2023 had performance conditions certified at 150% and 100% of target, with all such awards remaining subject to time-based vesting and scheduled to vest on February 27, 2026, while another restricted stock unit grant vests on its third anniversary.
The Hanover Insurance Group, Inc. is a Delaware-based holding company focused on U.S. property and casualty insurance sold through independent agents and brokers. For 2025, it generated approximately $6.3 billion in net premiums written, an increase of 3.9% from the prior year.
Business is organized into four segments: Core Commercial, Specialty, Personal Lines and Other. In 2025, Core Commercial wrote $2.3 billion of net premiums, Specialty $1.4 billion, and Personal Lines $2.6 billion, providing a diversified mix across commercial and personal auto, property and liability coverages.
Premiums are geographically concentrated, with Michigan and Massachusetts together representing 26.7% of total net premiums written. The company highlights exposure to catastrophe events, relies on extensive reinsurance (including catastrophe bonds), and carried a GAAP loss and loss adjustment expense reserve of $7.8 billion and investment assets and cash of $11.5 billion at December 31, 2025.
Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity transactions in company common stock. On February 5, 2026, he exercised a stock option for 17,420 shares at an exercise price of $77.91 per share and received common stock.
That same day, he sold several blocks of Hanover common stock at weighted average prices between $178.05 and $179.83, as detailed in the price ranges provided in the notes. He also made a charitable gift of 1,400 shares. Following all reported transactions, he directly owned 30,773.879 Hanover common shares.